- Home
- YRD vs AVIR Comparison
YRD vs AVIR Comparison
Compare YRD & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | YRD | AVIR |
|---|---|---|
| Founded | 2012 | 2012 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 321.4M | 318.0M |
| IPO Year | 2015 | 2020 |
Fundamental Metrics
Financial Performance| Metric | YRD | AVIR |
|---|---|---|
| Price | $3.60 | $6.06 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 34.6K | ★ 564.6K |
| Earning Date | 01-01-0001 | 06-01-2026 |
| Dividend Yield | ★ 12.36% | N/A |
| EPS Growth | N/A | ★ 3.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $351,367,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $1.86 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.51 | $2.46 |
| 52 Week High | $7.68 | $6.45 |
Technical Indicators
Market Signals| Indicator | YRD | AVIR |
|---|---|---|
| Relative Strength Index (RSI) | 40.98 | 77.25 |
| Support Level | $3.58 | $3.33 |
| Resistance Level | $3.98 | $6.45 |
| Average True Range (ATR) | 0.14 | 0.32 |
| MACD | -0.01 | 0.06 |
| Stochastic Oscillator | 19.15 | 81.98 |
Price Performance
Historical ComparisonAbout YRD Yiren Digital Ltd.
Yiren Digital Ltd is an AI-powered platform providing a comprehensive suite of financial and lifestyle services in China. Its mission is to elevate customers' financial well-being and enhance their quality of life by delivering digital financial services, tailor-made insurance solutions, and premium lifestyle services. The company supports clients at various growth stages, addressing financing needs arising from consumption and production activities, while aiming to augment the overall well-being and security of individuals, families, and businesses.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).